Bonaid TM

Research use only, not for human use.

(E)-[6]-Dehydroparadol shows growth inhibition and induction of apoptosis against human cancer cells(IC50 values of 43.02 μM in HCT-116 cell and 41.59 μM in H-1299 cell, respectively).

(E)-[6]-Dehydroparadol shows growth inhibition and induction of apoptosis against human cancer cells(IC50 values of 43.02 μM in HCT-116 cell and 41.59 μM in H-1299 cell, respectively).(In Vitro):(E)--Dehydroparadol (5-80 μM; 24 h) inhibits the growth of HCT-116 and H-1299 cells, with IC50s of 43.02 and 41.59 μM, respectively. (E)--Dehydroparadol (10-40 μM; 24 h) induces apoptosis in HCT-116 and H-1299 cells.(In Vivo):(E)--Dehydroparadol (5 μM; 24 h) enhances Tg[glutathione S-transferase pi 1 (gstp1):green fluorescent protein (GFP)] fluorescence signal in the Tg(gstp1:GFP) transgenic zebrafish embryos.

(E)--Dehydroparadol (M15) (5-80 μM; 24 h) inhibits the growth of HCT-116 and H-1299 cells, with IC50s of 43.02 and 41.59 μM, respectively.(E)--Dehydroparadol (10-40 μM; 24 h) induces apoptosis in HCT-116 and H-1299 cells.

(E)--Dehydroparadol (compound 19) (5 μM; 24 h) enhances Tg[glutathione S-transferase pi 1 (gstp1):green fluorescent protein (GFP)] fluorescence signal in the Tg(gstp1:GFP) transgenic zebrafish embryos.

(6)-Dehydroparadol

Others

Other Targets

——

——

——

878006-06-5

276.376

C17H24O3

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (361.83 mM)

CCCCCCCC(=O)\C=C\c1ccc(O)c(OC)c1

——

(-20℃)

With Ice Pack

≥ 2 years